LabCompass

Yichen Zhang

Medicine · Purdue University West Lafayette

Established · publishing since 1994Rising activity

Publications

84

Citations

1,186

Est. group size

Recurring co-author estimate

Active years

32

Publishing since 1994

Research summary
AI-generated

This name appears to be associated with a mix of research on cancer drug policy and economics, including studies on how cancer drugs are approved, priced, and reimbursed in countries like China, the US, and Australia, alongside work on lung cancer biomarkers and treatment. The publication record also includes unrelated topics such as biohybrid microrobots, gut microbiota, and language development, suggesting the name may represent multiple distinct researchers or highly diverse collaborations rather than a single coherent research program.

Cancer drug approval and regulatory policyHealth economics and reimbursement of cancer treatmentsLung cancer biomarkers and targeted therapyClinical trial evidence evaluationMiscellaneous biomedical and interdisciplinary topics

Publication output has grown over the last decade, rising from single digits in 2018 to a steady pace of about 12 papers per year from 2023 through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 8.8/year recently
2017: 8 publications172018: 1 publication182019: 6 publications192020: 5 publications202021: 11 publications212022: 8 publications222023: 12 publications12232024: 12 publications12242025: 12 publications122526
Recent publications
Publishes in
  • Journal of Thoracic Oncology×4
  • JAMA Network Open×3
  • BMJ Open×3
  • SSRN Electronic Journal×3
  • The Lancet Oncology×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile